Media thread, page-198

Hey hedrox,

Your comment, where is Player A, Craig? prompted me to go back and listen to the MST Access interview with Craig again.

9.50 is the discussion on Decentralized Clinical Trials.

CC:'We're really providing what our traditional trial partners have been asking for. Bayer, Astra Zeneca, GlaxoSmithKline, they've been looking for a wearable solution, they're going to go into pre-clinical trials with us on the ConneQt Band, and they are all moving towards Decentralized Clinical Trials. So given we have a direct partnership with them now, it's just natural for us to position ourselves with the next generation of devices."

19.00 Min Craig revisits the size of the DC Trials market:

CC:"Look at pharma company A, I'll call it, which is one of our existing trial partners. Pharma Company A has effectively come to us and said they want to be pre-launch partners with us across everything we are doing with our devices. So there's an embedded market for us from Day 1 with just 1 client."

Can't say for sure, but from these comments it's not a stretch to think Pharma Company A is either Bayer, AZ or GSK.